{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:15:18Z","timestamp":1777544118855,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.diabres.2018.02.027","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T22:10:26Z","timestamp":1519423826000},"page":"72-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A long-term quality-of-care score for predicting the occurrence of macrovascular diseases in patients with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"139","author":[{"given":"Pi-I","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"How-Ran","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2018.02.027_b0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2018.02.027_b0010","doi-asserted-by":"crossref","first-page":"650393","DOI":"10.1155\/2014\/650393","article-title":"Sequence variants of ADIPOQ and association with type 2 diabetes mellitus in Taiwan Chinese Han population","volume":"2014","author":"Tsai","year":"2014","journal-title":"Sci World J"},{"key":"10.1016\/j.diabres.2018.02.027_b0015","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/diacare.2.2.120","article-title":"Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study","volume":"2","author":"Kannel","year":"1979","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.02.027_b0020","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/PL00002934","article-title":"Mortality and causes of death in the WHO multinational study of vascular disease in diabetes","volume":"44","author":"Morrish","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2018.02.027_b0025","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s00125-006-0493-z","article-title":"Risk of stroke in people with type 2 diabetes in the UK: a study using the General practice research database","volume":"49","author":"Mulnier","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2018.02.027_b0030","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2337\/diacare.29.04.06.dc05-1433","article-title":"High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database","volume":"29","author":"Soedamah-Muthu","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.02.027_b0035","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-008-1076-y","article-title":"Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database","volume":"51","author":"Mulnier","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2018.02.027_b0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2337\/dc11-1682","article-title":"Nationwide study on trends in hospital admissions for major cardiovascular events and procedures among people with and without diabetes in England, 2004\u20132009","volume":"35","author":"Vamos","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.02.027_b0045","doi-asserted-by":"crossref","unstructured":"Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59.","DOI":"10.1056\/NEJMoa0802743"},{"key":"10.1016\/j.diabres.2018.02.027_b0050","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"10.1016\/j.diabres.2018.02.027_b0055","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"10.1016\/j.diabres.2018.02.027_b0060","doi-asserted-by":"crossref","unstructured":"Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, PROactive Investigators et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in thePROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 2005;366:1279\u201389.","DOI":"10.1016\/S0140-6736(05)67528-9"},{"key":"10.1016\/j.diabres.2018.02.027_b0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2018.02.027_b0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1900\/RDS.2004.1.29","article-title":"Adherence to guidelines and its effects on hospitalizations with complications of type 2 diabetes","volume":"1","author":"Sloan","year":"2004","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.diabres.2018.02.027_b0075","first-page":"161","article-title":"Who cares about the quality of diabetes care? Almost everyone.","volume":"16","author":"Mayfield","year":"1998","journal-title":"Diabetes Spectrum"},{"key":"10.1016\/j.diabres.2018.02.027_b0080","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2337\/diacare.19.6.601","article-title":"Quality of outpatient care provided to diabetic patients. A health maintenance organization experience","volume":"19","author":"Peters","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.02.027_b0085","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2337\/diacare.18.8.1124","article-title":"Physician and patient prevention practices in NIDDM in a large urban managed care organization","volume":"18","author":"Martin","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.02.027_b0090","doi-asserted-by":"crossref","unstructured":"TRIAD Study Group. The Translating Research Into Action for Diabetes (TRIAD) study: a multicenter study of diabetes in managed care. Diabetes Care 2002;25:386-9.","DOI":"10.2337\/diacare.25.2.386"},{"key":"10.1016\/j.diabres.2018.02.027_b0095","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.2337\/diacare.26.10.2722","article-title":"Improving diabetes processes of care in managed care","volume":"26","author":"Ilag","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.02.027_b0100","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2337\/diacare.24.10.1815","article-title":"The diabetes quality improvement project: moving science into health policy to gain an edge on the diabetes epidemic","volume":"24","author":"Fleming","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2018.02.027_b0105","doi-asserted-by":"crossref","unstructured":"Rossi MC, Lucisano G, Comaschi M, Coscelli C, Cucinotta D. et al. Quality of diabetes care predicts the development of cardiovascular events: results of the AMD-QUASAR study. Diabetes Care 2011;34:347-52.","DOI":"10.2337\/dc10-1709"},{"key":"10.1016\/j.diabres.2018.02.027_b0110","doi-asserted-by":"crossref","unstructured":"De Berardis G, Pellegrini F, Franciosi M, Belfiglio M, Di Nardo B, QuED (Quality of Care and Outcomes in Type 2 Diabetes) Study Group, et al. Quality of diabetes care predicts the development of cardiovascular events: results of the QuED study. Nutr Metab Cardiovasc Dis 2008;18:57-65.","DOI":"10.1016\/j.numecd.2006.04.009"},{"key":"10.1016\/j.diabres.2018.02.027_b0115","doi-asserted-by":"crossref","unstructured":"AmericanDiabetesAssociation. Standards of Medical Care in Diabetes-2015. Diabetes Care 2015;38:S1\u2013S94.","DOI":"10.2337\/dc15-S003"},{"key":"10.1016\/j.diabres.2018.02.027_b0120","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.ajkd.2006.10.007","article-title":"Epidemiological features of CKD in Taiwan","volume":"49","author":"Kuo","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2018.02.027_b0125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.18553\/jmcp.2009.15.4.312","article-title":"Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. Journal of managed care pharmacy","volume":"15","author":"Laliberte","year":"2009","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.diabres.2018.02.027_b0130","first-page":"15","article-title":"Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization","volume":"14","author":"Young","year":"2008","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.diabres.2018.02.027_b0135","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1345\/aph.1M570","article-title":"Refill adherence to oral hypoglycemic agents and glycemic control in veterans","volume":"44","author":"Kim","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.diabres.2018.02.027_b0140","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.Diabetologia 1991;34:877-90.","DOI":"10.1007\/BF00400195"},{"key":"10.1016\/j.diabres.2018.02.027_b0145","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2018.02.027_b0150","doi-asserted-by":"crossref","unstructured":"Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, CARDS investigators et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicenter randomised placebo-controlled trial. Lancet 2004;364:685-96.","DOI":"10.1016\/S0140-6736(04)16895-5"},{"key":"10.1016\/j.diabres.2018.02.027_b0155","doi-asserted-by":"crossref","unstructured":"Collins R, Armitage J, Parish S, Sleigh P, Peto R, Heart Protection Study Collaborative Group, et al. MRC\/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial. Lancet 2003;361:2005-16.","DOI":"10.1016\/S0140-6736(03)13636-7"},{"key":"10.1016\/j.diabres.2018.02.027_b0160","doi-asserted-by":"crossref","unstructured":"Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Blood Pressure Lowering Treatment Trialists' Collaboration, et al. Effects of different blood pressure lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med 2005;165:1410-9.","DOI":"10.1001\/archinte.165.12.1410"},{"key":"10.1016\/j.diabres.2018.02.027_b0165","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2018.02.027_b0170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.106.179294","article-title":"Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American heart association and the American diabetes association","volume":"115","author":"Buse","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2018.02.027_b0175","unstructured":"Bureau of National Health Insurance. National Health Insurance Pay-for Performance program for diabetes. Available at http:\/\/www.nhi.gov.tw\/webdata\/webdata.aspx?menu=20&menu_id=712&webdata_id=3862&W D_ID=836 [accessed 20.03.17]. [in Chinese]."},{"key":"10.1016\/j.diabres.2018.02.027_b0180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/MLR.0b013e31822d5d36","article-title":"A longitudinal examination of a pay-for-performance program for diabetes care: evidence from a natural experiment","volume":"50","author":"Cheng","year":"2012","journal-title":"Med Care"},{"key":"10.1016\/j.diabres.2018.02.027_b0185","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1472-6963-10-169","article-title":"Comparison of diabetes management in five countries for general and indigenous populations: an internet-based review","volume":"10","author":"Si","year":"2010","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.diabres.2018.02.027_b0190","doi-asserted-by":"crossref","unstructured":"Haffner SM, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.","DOI":"10.1056\/NEJM199807233390404"},{"key":"10.1016\/j.diabres.2018.02.027_b0195","unstructured":"Health Promotion Adminstration, Ministry of Health and Welfare, Taiwan. Health Indicators 123. Available at https:\/\/olap.hpa.gov.tw\/en_US\/Index.aspx?menu=-1&vid=1;[accessed 20.03.17]."}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717311051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717311051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T17:07:28Z","timestamp":1660496848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822717311051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":39,"alternative-id":["S0168822717311051"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2018.02.027","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A long-term quality-of-care score for predicting the occurrence of macrovascular diseases in patients with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2018.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}